UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sanofi gets nod to increase dosage for multiple sclerosis treatment
Sanofi Genzyme Korea said that the Ministry of Food and Drug safety has exp...
by Lee Han-soo
|
2019-01-28 17:02
라인
BMS withdraws Opdivo application for TMB high lung cancer in US
Bristol-Myers Squibb (BMS) said Thursday that it had voluntarily pulled its...
by Lee Han-soo
|
2019-01-28 15:25
라인
ISU Abxis confirms safety profile for immunotherapy candidate
ISU Abxis has published an interim report confirming the safety profile for...
by Lee Han-soo
|
2019-01-28 14:34
라인
4 local firms win exclusive rights to sell Pradaxa’s generic copies
The Supreme Court recently ruled that drugmakers’ alteration of an original...
by Lee Hye-seon
|
2019-01-28 11:56
라인
Humedix to supply osteoarthritis treatment to Huons, Shin Poong
Humedix said Thursday that it has signed an agreement to supply, sell and l...
by Lee Han-soo
|
2019-01-24 18:11
라인
US sales of J&J’s Remicade sink due to biosimilars’ challenge
The U.S. sales of Johnson & Johnson's (J&J) Remicade, a blockbuster ant...
by Lee Han-soo
|
2019-01-24 11:44
라인
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy
Kanzen said Tuesday that it has signed an agreement with Corea Therapeutics...
by Lee Han-soo
|
2019-01-23 21:29
라인
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
The Patent Court of Korea has rejected Jazz Pharmaceuticals’ application fo...
by Lee Hye-seon
|
2019-01-23 14:47
라인
Lilly returns rights for Hanmi’s BTK inhibitor candidate
Hanmi Pharmaceutical said Wednesday that Lilly has returned licensing right...
by Lee Han-soo
|
2019-01-23 10:21
라인
Bridge Biotherapeutics licenses in new targeted thearpy candidate
Bridge Biotherapeutics said Wednesday that it has signed a technology trans...
by Lee Han-soo
|
2019-01-23 10:20
라인
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has signed an agreement with Chong Kun D...
by Lee Han-soo
|
2019-01-22 16:03
라인
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’
The Korea Pharmaceutical Distribution Association (KPDA) is seeking to file...
by Park Gi-taek
|
2019-01-22 14:18
라인
BMS, Ono Pharma wins more indication for Opdivo in EU
Bristol-Myers Squibb (BMS) and Ono Pharma Korea have received an additional...
by Lee Han-soo
|
2019-01-21 18:01
라인
New HIV combo pill Biktarvy approved in Korea
Gilead Sciences said it has obtained approval for Biktarvy, a three-in-one ...
by Lee Hye-seon
|
2019-01-21 15:36
라인
JW wins sales go-ahead for hemophilia A treatment
JW Pharmaceutical said Sunday that the Ministry of Food and Drug Safety has...
by Lee Han-soo
|
2019-01-21 15:35
라인
Novo Nordisk increases market share for mixed insulin in Korea
Novo Nordisk Korea said Monday that Ryzodeg, the company’s soluble insulin ...
by Lee Han-soo
|
2019-01-21 14:44
라인
Sillajen releases interim results for combination cancer treatment in US
Sillajen said Monday that it has presented the National Cancer Institute’s ...
by Lee Han-soo
|
2019-01-21 14:20
라인
OliX unveils new drug candidate for treating geographic atrophy
Olix Pharmaceutical unveiled its latest drug candidate OLX10020, a treatmen...
by Lee Han-soo
|
2019-01-18 15:17
라인
‘Pharmaceuticals need President Moon’s committed support’
The chief of Korea’s representative biopharmaceutical industry group called...
by Lee Hye-seon
|
2019-01-17 17:39
라인
Daewoong to use cloud service for safe drug management
Daewoong Pharmaceutical said Thursday that it has introduced Oracle Argus C...
by Lee Han-soo
|
2019-01-17 15:37
-
이전
51
52
53
54
55
56
57
58
59
60
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top